These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17418595)

  • 1. Cisplatin cytotoxicity is enhanced with zoledronic acid in A549 lung cancer cell line: preliminary results of an in vitro study.
    Ozturk OH; Bozcuk H; Burgucu D; Ekinci D; Ozdogan M; Akca S; Yildiz M
    Cell Biol Int; 2007 Sep; 31(9):1069-71. PubMed ID: 17418595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid (Zometa) enhances the cytotoxic effect of gemcitabine and fluvastatin: in vitro isobologram studies with conventional and nonconventional cytotoxic agents.
    Budman DR; Calabro A
    Oncology; 2006; 70(2):147-53. PubMed ID: 16645328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid inhibits proliferation of human fibrosarcoma cells with induction of apoptosis, and shows combined effects with other anticancer agents.
    Koto K; Murata H; Kimura S; Horie N; Matsui T; Nishigaki Y; Ryu K; Sakabe T; Itoi M; Ashihara E; Maekawa T; Fushiki S; Kubo T
    Oncol Rep; 2010 Jul; 24(1):233-9. PubMed ID: 20514467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 T cell cytotoxicity.
    Mattarollo SR; Kenna T; Nieda M; Nicol AJ
    Cancer Immunol Immunother; 2007 Aug; 56(8):1285-97. PubMed ID: 17265022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KRAS-mutation status dependent effect of zoledronic acid in human non-small cell cancer preclinical models.
    Kenessey I; Kói K; Horváth O; Cserepes M; Molnár D; Izsák V; Dobos J; Hegedűs B; Tóvári J; Tímár J
    Oncotarget; 2016 Nov; 7(48):79503-79514. PubMed ID: 27780929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactive oxygen species and autophagy associated apoptosis and limitation of clonogenic survival induced by zoledronic acid in salivary adenoid cystic carcinoma cell line SACC-83.
    Ge XY; Yang LQ; Jiang Y; Yang WW; Fu J; Li SL
    PLoS One; 2014; 9(6):e101207. PubMed ID: 24963720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot studies of the effect of zoledronic acid (Zometa) on tumor-derived cells ex vivo in the ATP-based tumor chemosensitivity assay.
    Knight LA; Conroy M; Fernando A; Polak M; Kurbacher CM; Cree IA
    Anticancer Drugs; 2005 Oct; 16(9):969-76. PubMed ID: 16162973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bisphosphonate zoledronic acid effectively targets lung cancer cells by inhibition of protein prenylation.
    Xie F; Li P; Gong J; Zhang J; Ma J
    Biochem Biophys Res Commun; 2015 Nov; 467(4):664-9. PubMed ID: 26498526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic effect of zoledronic acid-loaded bone cement on giant cell tumor, multiple myeloma, and renal cell carcinoma cell lines.
    Zwolak P; Manivel JC; Jasinski P; Kirstein MN; Dudek AZ; Fisher J; Cheng EY
    J Bone Joint Surg Am; 2010 Jan; 92(1):162-8. PubMed ID: 20048108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth inhibition and sensitization to cisplatin by zoledronic acid in osteosarcoma cells.
    Benassi MS; Chiechi A; Ponticelli F; Pazzaglia L; Gamberi G; Zanella L; Manara MC; Perego P; Ferrari S; Picci P
    Cancer Lett; 2007 Jun; 250(2):194-205. PubMed ID: 17113707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of BK(Ca) channels in zoledronic acid-induced apoptosis of MDA-MB-231 breast cancer cells.
    Ma YG; Liu WC; Dong S; Du C; Wang XJ; Li JS; Xie XP; Wu L; Ma DC; Yu ZB; Xie MJ
    PLoS One; 2012; 7(5):e37451. PubMed ID: 22655048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25D3 enhances antitumor activity of gemcitabine and cisplatin in human bladder cancer models.
    Ma Y; Yu WD; Trump DL; Johnson CS
    Cancer; 2010 Jul; 116(13):3294-303. PubMed ID: 20564622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of sequence-dependent in vitro effects of zoledronic acid and paclitaxel upon human nasopharyngeal carcinoma cell line HNE1].
    Huang WL; Li XY; Wang HB; Lin W; Lin WZ; Lin SL; Lin YC
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1133-7. PubMed ID: 22781776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin in combination with zoledronic acid: a synergistic effect in triple-negative breast cancer cell lines.
    Ibrahim T; Liverani C; Mercatali L; Sacanna E; Zanoni M; Fabbri F; Zoli W; Amadori D
    Int J Oncol; 2013 Apr; 42(4):1263-70. PubMed ID: 23403907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
    Asbagh LA; Uzunoglu S; Cal C
    Int Braz J Urol; 2008; 34(3):355-63; discussion 364. PubMed ID: 18601766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
    Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laser-enhanced cytotoxicity of zoledronic acid and cisplatin on primary human fibroblasts and head and neck squamous cell carcinoma cell line UM-SCC-3.
    Heymann PG; Mandic R; Kämmerer PW; Kretschmer F; Saydali A; Neff A; Draenert FG
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1469-74. PubMed ID: 24947610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro antitumor effect of sodium butyrate and zoledronic acid combined with traditional chemotherapeutic drugs: a paradigm of synergistic molecular targeting in the treatment of Ewing sarcoma.
    Dos Santos MP; de Farias CB; Roesler R; Brunetto AL; Abujamra AL
    Oncol Rep; 2014 Feb; 31(2):955-68. PubMed ID: 24316794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.